APA (7th ed.) Citation

M, P., T, M., EJ, R., W, C., S, E., L, B., . . . CM, S. (2026). Neutrophil myeloperoxidase as a functional biomarker for RSV severity: Implications for in vitro therapeutic screening. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-74414-0

Chicago Style (17th ed.) Citation

M, Palor, et al. "Neutrophil Myeloperoxidase as a Functional Biomarker for RSV Severity: Implications for in Vitro Therapeutic Screening." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-74414-0.

MLA (9th ed.) Citation

M, Palor, et al. "Neutrophil Myeloperoxidase as a Functional Biomarker for RSV Severity: Implications for in Vitro Therapeutic Screening." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-74414-0.